- Home
- ZCMD vs SCNI Comparison
ZCMD vs SCNI Comparison
Compare ZCMD & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZCMD
- SCNI
- Stock Information
- Founded
- ZCMD 2012
- SCNI 2003
- Country
- ZCMD China
- SCNI Israel
- Employees
- ZCMD N/A
- SCNI N/A
- Industry
- ZCMD Other Consumer Services
- SCNI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ZCMD Real Estate
- SCNI Health Care
- Exchange
- ZCMD Nasdaq
- SCNI Nasdaq
- Market Cap
- ZCMD 3.4M
- SCNI 3.5M
- IPO Year
- ZCMD 2020
- SCNI N/A
- Fundamental
- Price
- ZCMD $1.20
- SCNI $2.84
- Analyst Decision
- ZCMD
- SCNI
- Analyst Count
- ZCMD 0
- SCNI 0
- Target Price
- ZCMD N/A
- SCNI N/A
- AVG Volume (30 Days)
- ZCMD 15.1K
- SCNI 12.9K
- Earning Date
- ZCMD 01-01-0001
- SCNI 11-29-2024
- Dividend Yield
- ZCMD N/A
- SCNI N/A
- EPS Growth
- ZCMD N/A
- SCNI N/A
- EPS
- ZCMD N/A
- SCNI N/A
- Revenue
- ZCMD $17,406,104.00
- SCNI $284,000.00
- Revenue This Year
- ZCMD N/A
- SCNI N/A
- Revenue Next Year
- ZCMD N/A
- SCNI N/A
- P/E Ratio
- ZCMD N/A
- SCNI N/A
- Revenue Growth
- ZCMD 1.01
- SCNI N/A
- 52 Week Low
- ZCMD $1.00
- SCNI $2.23
- 52 Week High
- ZCMD $9.90
- SCNI $8.92
- Technical
- Relative Strength Index (RSI)
- ZCMD 36.47
- SCNI 30.31
- Support Level
- ZCMD $1.17
- SCNI $2.91
- Resistance Level
- ZCMD $1.28
- SCNI $3.70
- Average True Range (ATR)
- ZCMD 0.09
- SCNI 0.21
- MACD
- ZCMD -0.00
- SCNI -0.07
- Stochastic Oscillator
- ZCMD 6.25
- SCNI 7.37
About ZCMD Zhongchao Inc.
ZHONGCHAO Inc is a Cayman Islands-based provider of healthcare information, education, and training services. It provides services to healthcare professionals and the public in China. It offers online and onsite health information services, healthcare education programs, and healthcare training products, consisting of clinical practice training, open classes of popular medical topics, interactive case studies, academic conferences and workshops, continuing education courses, and articles and short videos with educational healthcare content.
About SCNI Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company focused on developing, manufacturing and commercializing products for the prevention and treatment of infectious diseases and other illnesses. It has executed eight clinical trials in seven countries, around 12,400 participants in the Phase 3 trial of its vaccine candidate and has built a GMP biologics manufacturing facility for biopharmaceutical products. The company is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with a nanosized antibody (NanoAb) pipeline.